Both NAC and GSH treatments significantly increased the expression of stemness-related genes SMO, NANOG and OCT-4 at mRNA levels in all treated HCC cell lines (Fig. 4d). The gene discussed is POU5F1; the disease is hepatocellular carcinoma.